Inflammatory Bowel Disease in Cats: Management and Welfare

Feline Inflammatory Bowel Disease (IBD)

Inflammatory bowel disease (IBD) is one of the most common causes of chronic vomiting, diarrhoea, and weight loss in middle-aged to older cats. It represents a group of conditions characterised by idiopathic (unexplained) inflammatory infiltration of the gastrointestinal (GI) tract wall. Although often manageable, IBD significantly impacts quality of life and requires careful long-term welfare management. It must be distinguished from small cell lymphoma (a related but distinct condition) and other causes of chronic GI signs.

Pathophysiology

IBD results from dysregulation of the immune response to normal gut contents (food antigens, commensal bacteria), likely involving a combination of:

Genetic susceptibility to abnormal immune responses
Alterations in gut microbiome composition (dysbiosis)
Environmental triggers (dietary antigens, infections)
Compromised intestinal barrier function (leaky gut)

The result is chronic inflammation that damages the intestinal lining, impairing nutrient absorption and normal GI motility.

Types of Feline IBD

Lymphoplasmacytic enteritis: Most common form; affects small intestine primarily
Eosinophilic enteritis: Often associated with dietary hypersensitivity
Neutrophilic enteritis: Less common; may suggest bacterial infection component
Granulomatous enteritis: Rare; associated with FIP or fungal infections

Clinical Signs and Welfare Impact

IBD causes chronic, recurring signs that significantly reduce quality of life:

Chronic vomiting (often intermittent, but progressive)
Chronic diarrhoea or soft stools
Weight loss despite normal or increased appetite
Lethargy and reduced activity
Nausea signs: lip licking, drooling, reluctance to eat
Hyporexia or anorexia in severe cases
Abdominal discomfort (hunched posture, reluctance to be handled)

Cats with chronic nausea and abdominal discomfort experience ongoing suffering. Early diagnosis and management are essential welfare interventions.

Diagnosis

IBD diagnosis requires systematic investigation:

Full blood panel: Assess for anaemia, hypoproteinaemia, elevated liver enzymes
Cobalamin (B12) and folate: Cobalamin deficiency common with small intestinal IBD; requires supplementation
Feline pancreatic lipase (fPLI): Rule out pancreatitis (often concurrent)
Abdominal ultrasound: Assess bowel wall thickness, layering, and lymph node size
Endoscopy + mucosal biopsy: Definitive diagnosis; allows characterisation of inflammatory cell type
Full-thickness biopsy (surgical): Required when endoscopic biopsy is non-diagnostic or when lymphoma is strongly suspected

Note: Small cell lymphoma and IBD can look identical on ultrasound — tissue biopsy with immunohistochemistry is essential for differentiation. The distinction matters enormously as lymphoma responds to chlorambucil/prednisolone rather than diet alone.

Treatment and Management

Dietary Management

Dietary modification is often the first-line approach:

Novel protein diet: Use a protein source the cat has never been exposed to (rabbit, venison, duck, hydrolysed protein). Strict 8–12 week trial required
Highly digestible diet: Low-residue, high-digestibility diets reduce intestinal workload
Limited ingredient diets: Minimise antigenic load

Immunosuppressive Therapy

Prednisolone: 1–2 mg/kg/day initially, tapering as response occurs. Oral prednisolone preferred over dexamethasone in cats
Chlorambucil: Added for cats not responding to steroid alone, or to reduce steroid dose. Excellent safety profile in cats
Metronidazole: Anti-inflammatory and antimicrobial properties; often used as adjunct therapy

Cobalamin Supplementation

Cats with low B12 levels must be supplemented — deficiency impairs enterocyte function and worsens disease. Subcutaneous cyanocobalamin injections weekly for 6 weeks, then monthly, or oral supplementation (250μg daily).

Probiotic and Prebiotic Support

Emerging evidence supports gut microbiome modulation in feline IBD. Specific probiotic strains (VSL#3, Enterococcus faecium NCIMB 10415) may benefit some cats alongside conventional treatment.

Long-Term Welfare Monitoring

IBD is typically a lifelong condition requiring ongoing management:

Monthly body weight monitoring
Owner diary of vomiting frequency and stool consistency
3-monthly blood tests during stabilisation, 6-monthly when stable
Cobalamin recheck every 6 months
Quality of life assessment using validated feline chronic disease QoL tools